JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 14 July 2007. doi:10.1136/jcp.2007.050005
Journal of Clinical Pathology 2008;61:355-360
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2007.050005v1
61/3/355    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by D’Agaro, P
Right arrow Articles by Campello, C
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Agaro, P
Right arrow Articles by Campello, C
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Flu
*International Health

ORIGINAL ARTICLES

The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season

P D’Agaro1, T Rossi1, P Burgnich1, G Dal Molin1, N Coppola2, G Rocco2, C Campello1

1 Department of Public Medicine Sciences, U.C.O. Hygiene and Preventive Medicine, CIRI-IV, University of Trieste and IRCCS "Burlo Garofolo", Trieste, Italy
2 Friuli-Venezia Giulia Regional Health Direction, Trieste, Italy

Correspondence to:
Professor Cesare Campello, U.C.O. Hygiene and Preventive Medicine, Department of Public Medicine Sciences, Via dell’Istria 65/1, 34137 Trieste, Italy; campello{at}burlo.trieste.it

Aims: To analyse the epidemiological and molecular features of a long-lasting epidemic (12 weeks) of influenza in north-eastern Italy during the 2004–05 season.

Methods: Morbidity rates were analysed by time and age. Influenza virus isolates (93 strains) were submitted to antigenic evaluation by haemagglutination inhibition test and to molecular assessment by sequencing.

Results: The incidence peak (16.4 per thousand) was the highest recorded over the last six years in north-eastern Italy. The epidemic was sustained by two subsequent waves of circulating viruses: an H3N2 variant and two type B variants, respectively. In addition, scattered isolation of an H1N1 variant occurred. Antigenic and molecular characterisation showed the emergence of an H3N2 virus drifted with respect to vaccine strain, which also had a substantial impact on morbidity in vaccinated subjects. Moreover, a single K145N substitution in the HA1 site of H3N2 was the starting point of two evolutionary branches. No change was observed in H1N1 isolates. B-type virus was mainly represented by Victoria-lineage strains, though Yamagata-lineage viruses were also identified. The fluctuating circulation of these two clades has characterised B virus epidemics in recent years.

Conclusions: The assessment of the H3N2 molecular change in this area was in line with results used for establishing the vaccine composition for the incoming season. The particular epidemiological features of two B virus clades, namely Yamagata-like and Victoria-like, may be considered for introduction into the influenza vaccine.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.